Chapter

Pharmacologic Therapy of Systolic Ventricular Dysfunction and Heart Failure

Richard J. Rodeheffer and Margaret M. Redfield

in Mayo Clinic Cardiology

Fourth edition

Published on behalf of © Mayo Foundation for Medical Education and Research

Published in print November 2012 | ISBN: 9780199915712
Published online May 2013 | e-ISBN: 9780199322824 | DOI: http://dx.doi.org/10.1093/med/9780199915712.003.1822

Series: Mayo Clinic Scientific Press

Pharmacologic Therapy of Systolic Ventricular Dysfunction and Heart Failure

Show Summary Details

Preview

This chapter outlines guidelines and principles of pharmacologic treatment for systolic ventricular dysfunction and heart failure. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, digitalis glycosides, aldosterone antagonists, β-blockers, calcium channel blockers, inotropic agents, diuretics, hydralazine, and isosorbide are reviewed.

Chapter.  3532 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.